摘要目的 对人体内硒水平与骨质疏松及关节炎的相关性进行分析。方法 将2017年1月至2020年1月于我院就诊的125例骨质疏松患者(骨质疏松组)及117例骨关节炎患者(骨关节炎组)纳入研究,并选取同期121例于我院行常规体检的健康人群作为对照组;其中骨质疏松组患者男21例,女104例;平均年龄(66.15±4.78)岁,身体质量指数(body mass index,BMI)为(23.11±2.09)kg/m2,骨关节炎组患者男25例,女92例;平均年龄(67.83±4.81)岁,BMI(24.06±2.11)kg/m2。对照组患者男37例,女84例;平均年龄(65.39±4.92)岁,BMI(22.98±2.14)kg/m2。比较三组研究对象的血硒水平及骨密度等相关指标,并对血硒水平与骨质疏松及骨关节炎的相关性进行分析。结果 对照组及骨质疏松组的年龄、BMI明显低于骨关节炎组(P<0.05),而对照组患者的年龄及BMI与骨质疏松组相比,差异无统计学意义(P>0.05);骨质疏松组及骨关节炎组患者的骨密度、硒及骨钙素水平明显低于对照组,同时骨质疏松组明显低于骨关节炎组,Ⅰ型胶原交联C末端肽(C-telopeptide of type Ⅰ,CTX-Ⅰ)、Ⅰ型原胶原N端前肽(procollagen Ⅰ N-terminal propeptide,PⅠNP)水平明显高于对照组及骨关节炎组,差异均有统计学意义(P<0.05)。多因素Logistic分析示,高CTX-Ⅰ及PⅠNP水平是骨质疏松及骨关节炎的独立危险因素,而高骨密度、硒及骨钙素是防止骨质疏松及骨关节炎发生的保护因素。此外,女性为骨质疏松发生的独立危险因素,高龄及高BMI则为骨关节炎的独立危险因素(P<0.05);人体血硒水平与骨密度呈正相关(r=0.688,P<0.001)。结论 低血硒水平是发生骨质疏松及骨关节炎的独立危险因素,且血硒水平与患者骨密度呈正相关,可作为相关干预靶点。
Abstract:Objective To analyze the correlation between selenium level in human body and osteoporosis and arthritis.Methods 125 cases of osteoporosi(osteoporosis group) and 117 cases of osteoarthriti(osteoarthritis group) treated in our hospital from January 2017 to January 2020 were included in the study.121 cases were selected in our hospital during the same period.Healthy people undergoing routine physical examination in the hospital served as the control group.There were 21 males and 104 females in the osteoporosis group,with an average age of (66.15±4.78)years and a BMI of (23.11±2.09)kg/m2.There were 25 males and 92 females in the osteoarthritis group.The average age was (67.83±4.81)years old,and the BMI was(24.06±2.11)kg/m2.The control group included 37 males and 84 females.The average age was(65.39±4.92)years and the BMI was(22.98±2.14)kg/m2;The blood selenium level and bone density of the three groups of subjects were compared,and the correlation between the blood selenium level and osteoporosis and osteoarthritis was analyzed.Results The age and BMI of the control group and the osteoporosis group were significantly lower than those of the osteoarthritis group(P<0.05),while the age and BMI of the control group patients were not statistically different from those of the osteoporosis group(P>0.05).The bone density,selenium,and osteocalcin levels of the osteoporosis group and the osteoarthritis group were significantly lower than those of the control group,while the osteoporosis group was significantly lower than the osteoarthritis group.Type Ⅰ collagen cross-linked C-terminal peptide(C-The levels of telopeptide of type Ⅰ col I,CTX-Ⅰ) and procollagen Ⅰ N-terminal propeptide(PⅠNP) were significantly higher than those of the control group and the osteoarthritis group,and the differences were statistically significant (P<0.05).Multivariate logistic analysis showed that high CTX-Ⅰ and PⅠNP levels were independent risk factors for osteoporosis and osteoarthritis,while high bone density,selenium and osteocalcin were protective factors to prevent osteoporosis and osteoarthritis.In addition,femalewas independent risk factors for osteoporosis,while advanced age and high BMI were independent risk factors for osteoarthritis (P<0.05);Human blood selenium level was positively correlated with bone density (r=0.688,P<0.001).Conclusion Low blood selenium level is an independent risk factor for osteoporosis and osteoarthritis,and blood selenium level is positively correlated with patients' bone mineral density,which can be used as a relevant intervention target.
李磊,吴昊,吴良绍 *. 硒与骨质疏松和骨关节炎的相关性研究[J]. 实用骨科杂志, 2021, 27(8): 708-712.
Li Lei,Wu Hao,Wu Liangshao *. Study on the Relationship Between Selenium and Osteoporosis and Osteoarthritis. sygkzz, 2021, 27(8): 708-712.
[1]Chen CH,Lim SJ,Oh JK,et al.Teriparatide in east asian postmenopausal women with osteoporosis in a real-world setting:A baseline analysis of the asia and latin america fracture observational study(ALAFOS)[J].Clin Interv Aging,2020,15:111-121.
[2]Cornelissen D,de Kunder S,Si L,et al.Interventions to improve adherence to anti-osteoporosis medications:an updated systematic review[J].Osteoporos Int,2020,31(9):1645-1669.
[3]Fger-Samwald U,Dovjak P,Azizi-Semrad U,et al.Osteoporosis:Pathophysiology and therapeutic options[J].EXCLI J,2020(19):1017-1037.
[4]Zhou S,Tao Z,Zhu Y,et al.Mapping theme trends and recognizing hot spots in postmenopausal osteoporosis research:a bibliometric analysis[J].Peer J,2019(7):e8145.
[5]He Z,Chu L,Liu X,et al.Differences in subchondral trabecular bone microstructure and finite element analysis-based biomechanical properties between osteoporosis and osteoarthritis[J].J Orthop Translat,2020(24):39-45.
[6]Fragkiadaki P,Nikitovic D,Kalliantasi K,et al.Telomere length and telomerase activity in osteoporosis and osteoarthritis[J].Exp Ther Med,2020,19(3):1626-1632.
[7]Oo WM,Yu SP,Daniel MS,et al.Disease-modifying drugs in osteoarthritis:current understanding and future therapeutics[J].Expert Opin Emerg Drugs,2018,23(4):331-347.
[8]胡泽昆,吴霞,孙晓鹏,等.骨关节炎与骨质疏松的相关性研究[J].中国骨质疏松杂志,2017,23(2):259-261.
[9]Wang Y,Xie D,Li J,et al.Association between dietary selenium intake and the prevalence of osteoporosis:a cross-sectional study[J].BMC Musculoskelet Disord,2019,20(1):585.
[10]任世祥,赵潇雄,陈彤,等.硒纳米颗粒治疗类风湿关节炎大鼠效果观察及抗炎机制[J].山东医药,2020,60(4):43-47.
[11]刘强,马远征,王以朋,等.中国老年骨质疏松症诊疗指南(2018)[J].中国骨质疏松杂志,2018,24(12):1541-1567.
[12]中华医学会骨科学分会关节外科学组.骨关节炎诊疗指南(2018年版)[J].中华医学信息导报,2018,33(15):12.
[13]De Martinis M,Sirufo MM,Ginaldi L.Osteoporosis:Current and emerging therapies targeted to immunological checkpoints[J].Curr Med Chem,2020,27(37):6356-6372.
[14]Qiao L,Liu D,Li CG,et al.MiR-203 is essential for the shift from osteogenic differentiation to adipogenic differentiation of mesenchymal stem cells in postmenopausal osteoporosis[J].Eur Rev Med Pharmacol Sci,2018,22(18):5804-5814.
[15]Anton SD,Woods AJ,Ashizawa T,et al.Successful aging:Advancing the science of physical independence in older adults[J].Ageing Res Rev,2015,24(Pt B):304-327.
[16]Greco EA,Pietschmann P,Migliaccio S.Osteoporosis and sarcopenia increase frailty syndrome in the elderly[J].Front Endocrinol (Lausanne),2019(10):255.
[17]Hawker GA.Osteoarthritis is a serious disease[J].Clin Exp Rheumatol,2019,37 Suppl 120(5):3-6.
[18]Mobasheri A,Saarakkala S,Finnil M,et al.Recent advances in understanding the phenotypes of osteoarthritis[J].F1000 Res,2019(8):2091.
[19]Chow YY,Chin KY.The Role of Inflammation in the Pathogenesis of Osteoarthritis[J].Mediators Inflamm,2020(2020):8293921.
[20]Hou SM,Hou CH,Liu JF.CX3CL1 promotes MMP-3 production via the CX3CR1,c-Raf,MEK,ERK,and NF-κB signaling pathway in osteoarthritis synovial fibroblasts[J].Arthritis Res Ther,2017,19(1):282.
[21]孙凤娇,李艳,王雨心,等.膳食结构与硒对大鼠糖代谢的作用[J].山东大学学报(医学版),2020,58(2):36-43.
[22]Williams GR,Bassett J.Thyroid diseases and bone health[J].J Endocrinol Invest,2018,41(1):99-109.
[23]Pietschmann N,Rijntjes E,Hoeg A,et al.Selenoprotein P is the essential selenium transporter for bones[J].Metallomics,2014,6(5):1043-1049.
[24]Min Z,Zhao W,Zhong N,et al.Abnormality of epiphyseal plate induced by selenium deficiency diet in two generation DA rats[J].APMIS,2015,123(8):697-705.
[25]Medeiros DM.Copper,iron,and selenium dietary deficiencies negatively impact skeletal integrity:A review[J].Exp Biol Med (Maywood),2016,241(12):1316-1322.
[26]Kang P,Yao Y,Yang J,et al.An animal model of Kashin-Beck disease induced by a low-nutrition diet and exposure to T-2 toxin[J].Osteoarthritis Cartilage,2013,21(8):1108-1115.
[27]邱良武,何建辉,保文莉,等.补硒结合有氧运动对老年小鼠脏器系数、血生化和骨髓涂片的影响及意义[J].中国老年学杂志,2019,39(4):898-900.
[28]曹永成,杨爱花.武威市大骨节病与骨关节炎患者四种元素及炎症因子水平差异分析[J].国外医学(医学地理分册),2018,39(4):289-291.